Infection-associated vasculopathy in experimental chagas disease: Pathogenic roles of endothelin and kinin pathways

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 101-127

  Scharfstein, Julio ^a   Andrade, Daniele ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Bradykinin; Chagas disease; Cruzipain; Dendritic cells; Endothelin; GPCRs; Innate immunity; Kininogen; Microcirculation; Myocardiopathy; Myocarditis; TLR2; Toll like receptors; Trypanosoma cruzi; Vasculopathy

Indexed keywords

BRADYKININ B2 RECEPTOR; CARBOXYPEPTIDASE; CRUZIPAIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GAMMA INTERFERON; HIGH MOLECULAR WEIGHT KININOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; KININ; MUCIN; PATTERN RECOGNITION RECEPTOR; SIALIDASE; THROMBOXANE A2; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BOOK; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG MECHANISM; EDEMA; HEART MUSCLE FIBROSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INFECTION ASSOCIATED VASCULOPATHY; INFLAMMATION; INNATE IMMUNITY; KALLIKREIN KININ SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TH1 CELL; TISSUE CULTURE; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VASCULAR DISEASE;

ANIMALIA; TRYPANOSOMA CRUZI;

EID: 80052172817     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00005-0     Document Type: Chapter

References (118)

1. Albareda M.C., Laucella S.A., Alvarez M.G., Armenti A.H., Bertochi G., Tarleton R.L., et al. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int. Immunol. 2006, 18:465-471.
2. Aliberti J., Viola J.P., Vieira-De-Abreu A., Bozza P.T., Sher A., Scharfstein J. Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J. Immunol. 2003, 170:5349-5353.
3. Almeida I.C., Gazzinelli R.T. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 2001, 70:467-477.
4. Andrade S.G. Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones. Mem. Inst. Oswaldo Cruz 1999, 94(Suppl. 1):185-187.
5. Andrade Z.A., Andrade S.G., Correa R., Sadigursky M., Ferrans V.J. Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy. Am. J. Pathol. 1994, 144:1403-1411.
6. Andrade D., Serra R., Svensjö E., Lima A.P., Ramos Junior E., Fortes F., et al. Trypanosoma cruzi invades host cells through the activation of endothelin and kinin receptors: a converging pathway leading to chagasic vasculopathy. Br. J. Pharmacol. 2011, doi: 2010-BJP-1295-RP.R3.
7. Andrews N.W. Regulated secretion of conventional lysosomes. Trends Cell Biol. 2000, 10:316-321.
8. Aparicio I.M., Scharfstein J., Lima A.P. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 2004, 72:5892-5902.
9. Araujo F.F., Gomes J.A., Rocha M.O., Williams-Blangero S., Pinheiro V.M., Morato M.J., et al. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front. Biosci. 2007, 12:2797-2806.
10. Ashton A.W., Mukherjee S., Nagajyothi F.N., Huang H., Braunstein V.L., Desruisseaux M.S., et al. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J. Exp. Med. 2007, 204:929-940.
11. Bafica A., Santiago H.C., Goldszmid R., Ropert C., Gazzinelli R.T., Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 2006, 177:3515-3519.
12. Benvenuti L.A., Roggerio A., Freitas H.F., Mansur A.J., Fiorelli A., Higuchi M.L. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann. Trop. Med. Parasitol. 2008, 102:481-487.
13. Bertram C.M., Baltic S., Misso N.L., Bhoola K.D., Foster P.S., Thompson P.J., et al. Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration. J. Leukoc. Biol. 2007, 81:1445-1454.
14. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 1992, 44:1-80.
15. Burleigh B.A., Woolsey A.M. Cell signalling and Trypanosoma cruzi invasion. Cell. Microbiol. 2002, 4:701-711.
16. Calixto J.B., Medeiros R., Fernandes E.S., Ferreira J., Cabrini D.A., Campos M.M. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 2004, 143:803-818.
17. Cazzulo J.J., Couso R., Raimondi A., Wernstedt C., Hellman U. Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 1989, 33:33-41.
18. Coelho dos Santos J.S., Menezes C.A., Villani F.N., Magalhães L.M., Scharfstein J., Gollob K.J., et al. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clin. Exp. Immunol. 2010, 162:528-536.
19. Costa G.C., Da Costa Rocha M.O., Moreira P.R., Menezes C.A., Silva M.R., Gollob K.J., et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J. Infect. Dis. 2009, 199:451-454.
20. Cunha T.M., Verri W.A., Fukada S.Y., Guerrero A.T., Santodomingo-Garzon T., Poole S., et al. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur. J. Pharmacol. 2007, 573:221-229.
21. Danilov S.M., Sadovnikova E., Scharenborg N., Balyasnikova I.V., Svinareva D.A., Semikina E.L., et al. Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp. Hematol. 2003, 31:1301-1309.
22. De Freitas J.M., Augusto-Pinto L., Pimenta J.R., Bastos-Rodrigues L., Goncalves V.F., Teixeira S.M., et al. Ancestral genomes, sex, and the population structure of Trypanosoma cruzi. PLoS Pathog. 2006, 2:e24.
23. De Souza W. Structural organization of the cell surface of pathogenic protozoa. Micron 1995, 26:405-430.
24. Del Nery E.D., Juliano M.A., Meldal M., Svendsen I., Scharfstein J., Walmsley A., et al. Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides. Biochem. J. 1997, 323(Pt. 2):427-433.
25. Dhaun N., Pollock D.M., Goddard J., Webb D.J. Selective and mixed endothelin receptor antagonism in cardiovascular disease. Trends Pharmacol. Sci. 2007, 28:573-579.
26. Dias W.B., Fajardo F.D., Graca-Souza A.V., Freire-De-Lima L., Vieira F., Girard M.F., et al. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi. Cell. Microbiol. 2008, 10:88-99.
27. DiStasi M.R., Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol. 2009, 30:547-556. Review.
28. Doyle P.S., Zhou Y.M., Engel J.C., McKerrow J.H. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection. Antimicrob. Agents Chemother. 2007, 51:3932-3939.
29. Duthie M.S., Cetron M.S., Van Voorhis W.C., Kahn S.J. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes. Acta Trop. 2005, 93:317-329.
30. Filep J.G., Sirois M.G., Foldes-Filep E., Rousseau A., Plante G.E., Fournier A., et al. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br. J. Pharmacol. 1993, 109:880-886.
31. Fonseca S.G., Reis M.M., Coelho V., Nogueira L.G., Monteiro S.M., Mairena E.C., et al. Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy. Scand. J. Immunol. 2007, 66:362-371.
32. Garg N., Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 2002, 70:5547-5555.
33. Göbel K., Pankratz S., Schneider-Hohendorf T., Bittner S., Schuhmann M.K., Langer H.F., et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J. Autoimmun. 2011, 36:106-114.
34. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 2003, 71:1185-1193.
35. Goto K. Basic and therapeutic relevance of endothelin-mediated regulation. Biol. Pharm. Bull. 2001, 24:1219-1230.
36. Grisotto M.G., D'imperio Lima M.R., Marinho C.R., Tadokoro C.E., Abrahamsohn I.A., Alvarez J.M. Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology 2001, 102:209-217.
37. Herwald H., Hasan A.A., Godovac-Zimmermann J., Schmaier A.H., Muller-Esterl W. Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 1995, 270:14634-14642.
38. Herwald H., Collin M., Muller-Esterl W., Bjorck L. Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J. Exp. Med. 1996, 184:665-673.
39. Higuchi M.D., Ries M.M., Aiello V.D., Benvenuti L.A., Gutierrez P.S., Bellotti G., et al. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 1997, 56:485-489.
40. Higuchi M.L., Fukasawa S., De Brito T., Parzianello L.C., Bellotti G., Ramires J.A. Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 1999, 82:279-285.
41. Imamura T., Pike R.N., Potempa J., Travis J. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J. Clin. Invest. 1994, 94:361-367.
42. Imamura T., Tanase S., Szmyd G., Kozik A., Travis J., Potempa J. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J. Exp. Med. 2005, 201:1669-1676.
43. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnencak-Jones C.L., Mccurley T.L. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 1993, 48:348-357.
44. Kaman W.E., Wolterink A.F., Bader M., Boele L.C., van der Kleij D. The bradykinin B2 receptor in the early immune response against Listeria infection. Med. Microbiol. Immunol. 2009, 198:39-46.
45. Kedzierski R.M., Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 2001, 41:851-876.
46. Kozik A., Moore R.B., Potempa J., Imamura T., Rapala-Kozik M., Travis J. A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J. Biol. Chem. 1998, 273:33224-33229.
47. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30:16-34.
48. Leavey J.K., Tarleton R.L. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J. Immunol. 2003, 170:2264-2268.
49. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005, 57:27-77.
50. Leite M.F., Moyer M.S., Andrews N.W. Expression of the mammalian calcium signaling response to Trypanosoma cruzi in Xenopus laevis oocytes. Mol. Biochem. Parasitol. 1998, 92:1-13.
51. Libby P., Alroy J., Pereira M.E. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J. Clin. Invest. 1986, 77:127-135.
52. Lima A.P., Dos Reis F.C., Serveau C., Lalmanach G., Juliano L., Menard R., et al. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors. Mol. Biochem. Parasitol. 2001, 114:41-52.
53. Lima A.P., Almeida P.C., Tersariol I.L., Schmitz V., Schmaier A.H., Juliano L., et al. Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J. Biol. Chem. 2002, 277:5875-5881.
54. Macedo A.M., Pena S.D. Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitol. Today 1998, 14:119-124.
55. Marceau F., Bachvarov D.R. Kinin receptors. Clin. Rev. Allergy Immunol. 1998, 16:385-401.
56. Martin D.L., Weatherly D.B., Laucella S.A., Cabinian M.A., Crim M.T., Sullivan S., et al. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2006, 2:e77.
57. McLean P., Ahluvalia A., Perretti A. Association between kinin B1 receptor expression and leukocyte trafficking across mesenteric postcapillary venules. J. Exp. Med. 2001, 192:367-380.
58. Monteiro A.C., Abrahamson M., Lima A.P., Vannier-Santos M.A., Scharfstein J. Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi. J. Cell Sci. 2001, 114:3933-3942.
59. Monteiro A.C., Schmitz V., Svensjo E., Gazzinelli R.T., Almeida I.C., Todorov A., et al. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J. Immunol. 2006, 177:6325-6335.
60. Monteiro A.C., Schmitz V., Morrot A., De Arruda L.B., Nagajyothi F., Granato A., et al. Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog. 2007, 3:e185.
61. Monteiro A.C., Scovino A., Raposo S., Gaze V.M., Cruz C., Svensjo E., et al. Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. J. Immunol. 2009, 183:3700-3711.
62. Morand-Contant M., Anand-Srivastava M.B., Couture R. Kinin B1 receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H1625-H1632.
63. Morris S.A., Tanowitz H.B., Wittner M., Bilezikian J.P. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 1990, 82:1900-1909.
64. Morrot A., Strickland D.K., Higuchi Mde L., Reis M., Pedrosa R., Scharfstein J. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes. Int. Immunol. 1997, 9:825-834.
65. Mukherjee S., Huang H., Petkova S.B., Albanese C., Pestell R.G., Braunstein V.L., et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 2004, 72:5274-5282.
66. Murta A.C., Persechini P.M., Padron Tde S., De Souza W., Guimaraes J.A., Scharfstein J. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol. Biochem. Parasitol. 1990, 43:27-38.
67. Oliveira A.C., de Alencar B.C., Tzelepis F., Klezewsky W., da Silva R.N., Neves F.S., et al. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice. PLoS Pathog. 2010, 6:e1000870.
68. Palomino S.A., Aiello V.D., Higuchi M.L. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann. Trop. Med. Parasitol. 2000, 94:571-579.
69. Parkin E.T., Turner A.J., Hooper N.M. Secretase-mediated cell surface shedding of the angiotensin-converting enzyme. Protein Pept. Lett. 2004, 11:423-432.
70. Petkova S.B., Tanowitz H.B., Magazine H.I., Factor S.M., Chan J., Pestell R.G., et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 2000, 9:257-265.
71. Previato J.O., Andrade A.F., Pessolani M.C., Mendonça-Previato L. Incorporation of sialic acid into Trypanosoma cruzi macromolecules. A proposal for a new metabolic route. Mol. Biochem. Parasitol. 1985, 16:85-96.
72. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Gazzinelli G., Colley D.G., et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 1993, 48:637-644.
73. Renne T., Muller-Esterl W. Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen. FEBS Lett. 2001, 500:36-40.
74. Renne T., Dedio J., David G., Muller-Esterl W. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 2000, 275:33688-33696.
75. Ribeiro Dos Santos, Hudson L. Denervation and the immune response in mice infected with Trypanosoma cruzi. Clin. Exp. Immunol. 1981, 44:349-354.
76. Rosenberg C.S., Martin D.L., Tarleton R.L. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J. Immunol. 2010, 185:560-568.
77. Rossi M.A. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am. Heart J. 1990, 120:233-236.
78. Salomone O.A., Caeiro T.F., Madoery R.J., Amuchastegui M., Omelinauk M., Juri D., et al. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am. J. Cardiol. 2001, 87:1217-1220. A1217.
79. Sampaio A.L., Rae G.A., Henriques M.G. Participation of endogenous endothelins in delayed eosinophil and neutrophil recruitment in mouse pleurisy. Inflamm. Res. 2000, 49:170-176.
80. Sansonetti P.J. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 2006, 7:1237-1242.
81. Scharfstein J. Trypanosoma cruzi cysteine proteases, acting in the interface between the vascular and immune systems, influence pathogenic outcome in experimental Chagas disease. Open Parasitol. 2010, 4:60-71.
82. Scharfstein J., Lima A.P. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi. Subcell. Biochem. 2008, 47:140-154.
83. Scharfstein J., Morrot A. A role for extracellular amastigotes in the immunopathology of Chagas disease. Mem. Inst. Oswaldo Cruz 1999, 94(Suppl. 1):51-63.
84. Scharfstein J., Schmitz V., Morandi V., Capella M.M., Lima A.P., Morrot A., et al. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J. Exp. Med. 2000, 192:1289-1300.
85. Scharfstein J., Schmitz V., Svensjo E., Granato A., Monteiro A.C. Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand. J. Immunol. 2007, 66:128-136.
86. Scharfstein J., Monteiro A.C., Schmitz V., Svensjo E. Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway. Biol. Chem. 2008, 389:1015-1024.
87. Schmaier A.H. The physiologic basis of assembly and activation of the plasma kallikrein/kinin system. Thromb. Haemost. 2004, 91:1-3.
88. Schmitz V., Svensjo E., Serra R.R., Teixeira M.M., Scharfstein J. Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors. J. Leukoc. Biol. 2009, 85:1005-1014.
89. Schwarting A., Schlaak J., Lotz J., Pfers I., Meyer Zum Buschenfelde K.H., Mayet W.J. Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS). Scand. J. Rheumatol. 1996, 25:246-256.
90. Shortman K., Naik S.H. Steady-state and inflammatory dendritic cell development. Nat. Rev. 2007, 7:19-30.
91. Silva G.K., Gutierrez F.R., Guedes P.M., Horta C.V., Cunha L.D., Mineo T.W., et al. Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J. Immunol. 2010, 184:1148-1152.
92. Skidgel R.A., Erdos E.G. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides 2004, 25:521-525.
93. Souto-Padron T., Campetella O.E., Cazzulo J.J., De Souza W. Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction. J. Cell Sci. 1990, 96(Pt 3):485-490.
94. Souza P.E., Rocha M.O., Menezes C.A., Coelho J.S., Chaves A.C., Gollob K.J., et al. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Infect. Immun. 2007, 75:1886-1894.
95. Speciale L., Roda K., Saresella M., Taramelli D., Ferrante P. Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line. Immunology 1998, 93:109-114.
96. Stoka V., Nycander M., Lenarcic B., Labriola C., Cazzulo J.J., Bjork I., et al. Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily. FEBS Lett. 1995, 370:101-104.
97. Sturm N.R., Campbell D.A. Alternative lifestyles: the population structure of Trypanosoma cruzi. Acta Trop. 2009, 115:35-43.
98. Tanowitz H.B., Wittner M., Morris S.A., Zhao W., Weiss L.M., Hatcher V.B., et al. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by Trypanosoma cruzi. Endothelium 1999, 6:217-230.
99. Tanowitz H.B., Huang H., Jelicks L.A., Chandra M., Loredo M.L., Weiss L.M., et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect. Immun. 2005, 73:2496-2503.
100. Tardieux I., Webster P., Ravesloot J., Boron W., Lunn J.A., Heuser J.E., et al. Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 1992, 71:1117-1130.
101. Tarleton R.L. Chagas disease: a role for autoimmunity?. Trends Parasitol. 2003, 19:447-451.
102. Tarleton R.L., Sun J., Zhang L., Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 1994, 62:1820-1829.
103. Teixeira A.R., Gomes C., Nitz N., Sousa A.O., Alves R.M., Guimaro M.C., et al. Trypanosoma cruzi in the chicken model: Chagas-like heart disease in the absence of parasitism. PLoS Negl Trop Dis. 2011, 5:e1000.
104. Tibayrenc M., Hoffmann A., Poch O., Echalar L., Le Pont F., Lemesre J.L., et al. Additional data on Trypanosoma cruzi isozymic strains encountered in Bolivian domestic transmission cycles. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:442-447.
105. Todorov A.G., Andrade D., Pesquero J.B., Araujo Rde C., Bader M., Stewart J., et al. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J. 2003, 17:73-75.
106. Tonelli R.R., Giordano R.J., Barbu E.M., Torrecilhas A.C., Kobayashi G.S., Langley R.R., et al. Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo. PLoS Negl. Trop. Dis. 2010, 4:e864.
107. Trocoli Torrecilhas A.C., Tonelli R.R., Pavanelli W.R., da Silva J.S., Schumacher R.I., de Souza W.E., et al. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 2009, 11:29-39.
108. Tyler K.M., Luxton G.W., Applewhite D.A., Murphy S.C., Engman D.M. Responsive microtubule dynamics promote cell invasion by Trypanosoma cruzi. Cell. Microbiol. 2005, 11:1579-1591.
109. Tzelepis F., De Alencar B.C., Penido M.L., Claser C., Machado A.V., Bruna-Romero O., et al. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J. Immunol. 2008, 180:1737-1748.
110. Vago A.R., Macedo A.M., Oliveira R.P., Andrade L.O., Chiari E., Galvao L.M., et al. Kinetoplast DNA signatures of Trypanosoma cruzi strains obtained directly from infected tissues. Am. J. Pathol. 1996, 149:2153-2159.
111. Vago A.R., Andrade L.O., Leite A.A., D'avila Reis D., Macedo A.M., Adad S.J., et al. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am. J. Pathol. 2000, 156:1805-1809.
112. Venegas J., Conoepan W., Pichuantes S., Miranda S., Jercic M.I., Gajardo M., et al. Phylogenetic analysis of microsatellite markers further supports the two hybridization events hypothesis as the origin of the Trypanosoma cruzi lineages. Parasitol. Res. 2009, 105:191-199.
113. Westenberger S.J., Barnabe C., Campbell D.A., Sturm N.R. Two hybridization events define the population structure of Trypanosoma cruzi. Genetics 2005, 171:527-543.
114. Wizel B., Nunes M., Tarleton R.L. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J. Immunol. 1997, 159:6120-6130.
115. Zhang L., Tarleton R.L. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp. Parasitol. 1996, 84:203-213.
116. Zingales B., Carniol C., de Lederkremer R.M., Colli W. Direct sialic acid transfer from a protein donor to glycolipids of trypomastigote forms of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1987, 26:135-144.
117. Zingales B., Andrade S.G., Briones M.R., Campbell D.A., Chiari E., Fernandes O., et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 2009, 104:1051-1054.
118. Zouki C., Baron C., Fournier A., Filep J.G. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br. J. Pharmacol. 1999, 127:969-979.